{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:42:12Z","timestamp":1793234532843,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014761","name":"Natural Science Foundation of Qingdao","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cellsig.2026.112441","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:23:56Z","timestamp":1771633436000},"page":"112441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["GNE-493 suppresses gastric cancer development by targeting NAT10-mediated ac4C modification of HK2"],"prefix":"10.1016","volume":"143","author":[{"given":"Tengkai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoyang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2026.112441_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112441_bb0010","doi-asserted-by":"crossref","first-page":"5826","DOI":"10.7150\/thno.108817","article-title":"GPX4 knockdown suppresses M2 macrophage polarization in gastric cancer by modulating kynurenine metabolism","volume":"15","author":"Xu","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2026.112441_bb0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S2468-1253(19)30332-2","article-title":"Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trial","volume":"5","author":"Katai","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0020","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1200\/JCO.22.02867","article-title":"Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric Cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial","volume":"42","author":"Rau","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0025","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1200\/JCO.1995.13.10.2643","article-title":"Docetaxel","volume":"13","author":"Cortes","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S1470-2045(23)00541-7","article-title":"Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study","volume":"25","author":"Shitara","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0035","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1158\/1078-0432.CCR-20-4691","article-title":"Camrelizumab combined with chemotherapy followed by Camrelizumab plus Apatinib as first-line therapy for advanced gastric or gastroesophageal junction adenocarcinoma","volume":"27","author":"Peng","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0040","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1093\/annonc\/mdf302","article-title":"A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer","volume":"13","author":"Chang","year":"2002","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0045","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s10120-013-0249-7","article-title":"Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase","volume":"17","author":"Nakamura","year":"2014","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.cellsig.2026.112441_bb0050","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s43188-020-00044-3","article-title":"Celecoxib induces apoptosis through Akt inhibition in 5-fluorouracil-resistant gastric cancer cells","volume":"37","author":"Choi","year":"2021","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0055","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1038\/s41388-024-03185-z","article-title":"m(6)A-driven NAT10 translation facilitates fatty acid metabolic rewiring to suppress ferroptosis and promote ovarian tumorigenesis through enhancing ACOT7 mRNA acetylation","volume":"43","author":"Liu","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2026.112441_bb0060","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112441_bb0065","article-title":"NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cellsig.2026.112441_bb0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1158\/0008-5472.CAN-20-1619","article-title":"DMDRMR-mediated regulation of m(6)A-modified CDK4 by m(6)A reader IGF2BP3 drives ccRCC progression","volume":"81","author":"Gu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0075","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1158\/0008-5472.CAN-22-2233","article-title":"NAT10 drives cisplatin chemoresistance by enhancing ac4C-associated DNA repair in bladder cancer","volume":"83","author":"Xie","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112810","article-title":"NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer","volume":"42","author":"Wei","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cellsig.2026.112441_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202302705","article-title":"NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer","volume":"10","author":"Chen","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2026.112441_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103145","article-title":"The positive feedback loop of the NAT10\/Mybbp1a\/p53 axis promotes cardiomyocyte ferroptosis to exacerbate cardiac I\/R injury","volume":"72","author":"Qu","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0095","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13072-023-00501-x","article-title":"PARP-dependent and NAT10-independent acetylation of N4-cytidine in RNA appears in UV-damaged chromatin","volume":"16","author":"Svobodov\u00e1 Kova\u0159\u00edkov\u00e1","year":"2023","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.cellsig.2026.112441_bb0100","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","article-title":"Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer","volume":"48","author":"Liu","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0105","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.7150\/ijbs.113325","article-title":"Targeting the NAT10\/XIST\/YAP1 Axis-mediated vascular Abnormalization enhances immune checkpoint blockade in gastric cancer","volume":"21","author":"Lei","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.cellsig.2026.112441_bb0110","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12943-015-0361-x","article-title":"The role of the PI3K\/Akt\/mTOR signalling pathway in human cancers induced by infection with human papillomaviruses","volume":"14","author":"Zhang","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cellsig.2026.112441_bb0115","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/med.21770","article-title":"Targeting phosphatidylinositol 3-kinase gamma (PI3K\u03b3): discovery and development of its selective inhibitors","volume":"41","author":"Zhu","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.cellsig.2026.112441_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105579","article-title":"Properties of FDA-approved small molecule phosphatidylinositol 3-kinase inhibitors prescribed for the treatment of malignancies","volume":"168","author":"Roskoski","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0125","article-title":"Author correction: proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cellsig.2026.112441_bb0130","article-title":"IL-4\/IL-4R axis signaling drives resistance to immunotherapy by inducing the upregulation of Fc\u03b3 receptor IIB in M2 macrophages","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112441_bb0135","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1021\/jm901284w","article-title":"Discovery of (thienopyrimidin-2-yl)aminopyrimidines as potent, selective, and orally available pan-PI3-kinase and dual pan-PI3-kinase\/mTOR inhibitors for the treatment of cancer","volume":"53","author":"Sutherlin","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cellsig.2026.112441_bb0140","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41420-022-00911-y","article-title":"GNE-493 inhibits prostate cancer cell growth via Akt-mTOR-dependent and -independent mechanisms","volume":"8","author":"Jin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112441_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111747","article-title":"PI3K\u03b1 inhibitor GNE-493 triggers antitumor immunity in murine lung cancer by inducing immunogenic cell death and activating T cells","volume":"130","author":"Xue","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0150","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-022-05219-4","article-title":"The MBNL1\/circNTRK2\/PAX5 pathway regulates aerobic glycolysis in glioblastoma cells by encoding a novel protein NTRK2-243aa","volume":"13","author":"Zhao","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112441_bb0155","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112441_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41392-025-02226-7","article-title":"Single-cell transcriptomic analysis reveals gut microbiota-immunotherapy synergy through modulating tumor microenvironment","volume":"10","author":"Cao","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112441_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217159","article-title":"RNA ac(4)C modification in cancer: Unraveling multifaceted roles and promising therapeutic horizons","volume":"601","author":"Ouyang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2026.112441_bb0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41392-021-00489-4","article-title":"NAT10 promotes gastric cancer metastasis via N4-acetylated COL5A1","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cellsig.2026.112441_bb0175","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13046-024-03200-x","article-title":"NAT10\/ac4C\/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction","volume":"43","author":"Li","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0180","article-title":"Paeonol inhibits the glycolysis in oral squamous cell carcinoma though suppressing NAT10-mediated ac(4)C modification","volume":"25","author":"Yang","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cellsig.2026.112441_bb0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-024-06615-8","article-title":"PQR309, a dual PI3K\/mTOR inhibitor, synergizes with gemcitabine by impairing the GSK-3\u03b2 and STAT3\/HSP60 signaling pathways to treat nasopharyngeal carcinoma","volume":"15","author":"Cao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cellsig.2026.112441_bb0190","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.apsb.2025.03.042","article-title":"NAT10 inhibition alleviates astrocyte autophagy by impeding ac4C acetylation of Timp1 mRNA in ischemic stroke","volume":"15","author":"Yang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112441_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.70070","article-title":"The microbiome in cancer","volume":"4","author":"Lin","year":"2025","journal-title":"iMeta"},{"key":"10.1016\/j.cellsig.2026.112441_bb0200","article-title":"Natural killer cell immune checkpoints and their therapeutic targeting in cancer treatment","volume":"8","author":"Lin","year":"2025","journal-title":"Research (Washington, D.C.)"},{"key":"10.1016\/j.cellsig.2026.112441_bb0205","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/s41418-018-0227-z","article-title":"Mutant p53-dependent mitochondrial metabolic alterations in a mesenchymal stem cell-based model of progressive malignancy","volume":"26","author":"Lonetto","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2026.112441_bb0210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gendis.2019.10.007","article-title":"Metabolic reprogramming in tumors: contributions of the tumor microenvironment","volume":"7","author":"Lane","year":"2020","journal-title":"Genes Diseas."},{"key":"10.1016\/j.cellsig.2026.112441_bb0215","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1038\/s41418-019-0450-2","article-title":"Epigenetic regulation of the Warburg effect by H2B monoubiquitination","volume":"27","author":"Jing","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cellsig.2026.112441_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01215","article-title":"The metabolic landscape of lung cancer: new insights in a disturbed glucose metabolism","volume":"9","author":"Vanhove","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0225","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even Warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2026.112441_bb0230","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-021-00378-6","article-title":"Cancer metabolism: looking forward","volume":"21","author":"Mart\u00ednez-Reyes","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112441_bb0235","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.aaf6284","article-title":"Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism","volume":"354","author":"Peng","year":"2016","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.cellsig.2026.112441_bb0240","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41577-020-0406-2","article-title":"Lactate modulation of immune responses in inflammatory versus tumour microenvironments","volume":"21","author":"Certo","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0245","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112441_bb0250","doi-asserted-by":"crossref","DOI":"10.2174\/0118761429308361240823061634","article-title":"Recent advances in the glycolytic processes linked to tumor metastasis","volume":"17","author":"Qiong","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112441_bb0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellsig.2026.112441_bb0260","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41576-020-00295-8","article-title":"The epitranscriptome beyond m(6)A","volume":"22","author":"Wiener","year":"2021","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cellsig.2026.112441_bb0265","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.cell.2018.10.030","article-title":"Acetylation of cytidine in mRNA promotes translation efficiency","volume":"175","author":"Arango","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cellsig.2026.112441_bb0270","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.7150\/thno.104310","article-title":"Glucose homeostasis controls N-acetyltransferase 10-mediated ac4C modification of HK2 to drive gastric tumorigenesis","volume":"15","author":"Wang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.cellsig.2026.112441_bb0275","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202370155","article-title":"N4-acetylcytidine drives glycolysis addiction in gastric cancer via NAT10\/SEPT9\/HIF-1\u03b1 positive feedback loop","volume":"10","author":"Yang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.cellsig.2026.112441_bb0280","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1158\/0008-5472.CAN-23-4062","article-title":"NAT10 phase separation regulates YTHDF1 splicing to promote gastric cancer progression","volume":"84","author":"Liu","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112441_bb0285","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13046-022-02586-w","article-title":"Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression","volume":"42","author":"Deng","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000914?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000914?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:27:38Z","timestamp":1777580858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826000914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S0898656826000914"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112441","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GNE-493 suppresses gastric cancer development by targeting NAT10-mediated ac4C modification of HK2","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112441"}}